Showing results (121-130 of 255) with videos related to
Sort By:
Pageof 26
Muscle & Nerve|March 21, 2013
Fast skeletal muscle troponin activator in the dy2J muscular dystrophy modelJessica J Miciak, Leigh C Warsing, Maria E Tibbs, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 7, 2018
VITALITY-ALS, a phase III trial of tirasemtiv, a selective fast skeletal muscle troponin activator, as a potential treatment for patients with amyotrophic lateral sclerosis: study design and baseline characteristicsJinsy A Andrews, Merit E Cudkowicz, Orla Hardiman, et al.Health and Quality of Life Outcomes|September 16, 2016
Incorporating development of a patient-reported outcome instrument in a clinical drug development program: examples from a heart failure programIngela Wiklund, Milena Anatchkova, Hafiz Oko-Osi, et al.Ophthalmic Plastic and Reconstructive Surgery|April 8, 2026
Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Thyroid Eye DiseaseJawad Muayad, Muhammad Z Chauhan, Leo M Hall, et al.Plos One|May 9, 2014
Fast skeletal muscle troponin activator tirasemtiv increases muscle function and performance in the B6SJL-SOD1G93A ALS mouse modelDarren T Hwee, Adam Kennedy, Julie Ryans, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|February 24, 2009
Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvementJ D Fenwick, A E Nahum, Z I Malik, et al.Facial Plastic Surgery : FPS|March 27, 2024
Perceptions and Understanding of Transgender Patient Care: A Survey of Practicing Facial Plastic SurgeonsMegan L Swonke, Anthony E Brissett, Najm S Khan, et al.Veterinary Medicine and Science|June 1, 2018
Molecular detection of Ehrlichia canis in dogs from three districts in Punjab (Pakistan)Muhammad I Malik, Muhammad Qamar, Quratul Ain, et al.Journal of Neuro-Oncology|August 24, 2010
Temporal lobe pleomorphic xanthoastrocytoma and acquired BRAF mutation in an adolescent with the constitutional 22q11.2 deletion syndromeJeffrey C Murray, David J Donahue, Saleem I Malik, et al.The Journal of Pharmacology and Experimental Therapeutics|July 26, 2011
Inhibition of smooth muscle myosin as a novel therapeutic target for hypertensionXin Zhao, David Ho, Patricio Abarzúa, et al.Pageof 26